Competing with Felix, Hims & Truepill: The Clinic Advantage
Clinics often fear that direct-to-consumer telehealth giants like Hims, Felix, and Truepill will make them obsolete.
In reality, clinics have structural advantages that DTC brands can’t replicate.
Here’s how to compete—and win.
1. Real Medical Trust
Hims & co. sell volume, not care. Patients know it.
Clinics have:
Credentials
Continuity of care
Physical presence
This builds longer retention and deeper trust. CCI helps digitize that trust into UX and workflow.
2. You Control Outcomes
DTC brands prescribe fast. Clinics prescribe well.
When you show real protocols, treatment plans, and skin journeys, patients stick.
CCI powers:
Protocol-based selling
Dynamic follow-ups
Embedded education
3. Product Quality
Clinics can offer:
Higher potency actives
Personalized scripts
White-label customization
DTC brands can't match that level of precision.
4. You Already Have the Relationship
Your patients already see you for Botox, peels, laser, or acne management.
Why let Hims monetize the homecare?
With CCI:
Launch your store in weeks
Auto-route your in-clinic patients to online protocols
Own 100% of the post-visit revenue
5. CCI Gives You the Tech
We studied the Felix and Truepill stacks. Then we built a better one—compliant, clinical, customizable.
You don’t need VC funding or a tech team.
You need CCI.
Conclusion
You’re not behind.
You’re sitting on the most powerful edge in clinical skincare—and now, with CCI, you have the tools to scale it.